diminazene has been researched along with Cardiovascular Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Bessa, ASM; Biancardi, MF; Castro, CH; Colugnati, DB; Costa, JM; Dos Santos, FCA; Jesus, ÉF; Lacerda, IS; Lino-Júnior, RS; Mazaro-Costa, R; Mendes, EP; Nunes, ADC; Pedrino, GR; Pontes, CNR; Souza, EJ | 1 |
Apostolopoulos, V; Egom, EE; Gadanec, LK; Kruzliak, P; Kubatka, P; Levinger, I; McSweeney, KR; Qaradakhi, T; Rimarova, K; Rodrigo, L; Tacey, A; Zulli, A | 1 |
Duan, W; Liu, J; Ma, Y; Xia, L; Yu, S; Zhai, M; Zhang, L; Zhu, H | 1 |
2 review(s) available for diminazene and Cardiovascular Diseases
Article | Year |
---|---|
The potential actions of angiotensin-converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases.
Topics: Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Diseases; Diminazene; Enzyme Activation; Enzyme Activators; Humans; Neoplasms; Renin-Angiotensin System | 2020 |
The role of SARS-CoV-2 target ACE2 in cardiovascular diseases.
Topics: Angiotensin-Converting Enzyme 2; Animals; Arrhythmias, Cardiac; Cardiovascular Diseases; COVID-19; COVID-19 Drug Treatment; Diminazene; Heart Failure; Humans; Hypertension; Myocardial Infarction; Recombinant Proteins | 2021 |
1 other study(ies) available for diminazene and Cardiovascular Diseases
Article | Year |
---|---|
Stimulation of the ACE2/Ang-(1-7)/Mas axis in hypertensive pregnant rats attenuates cardiovascular dysfunction in adult male offspring.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cardiovascular Diseases; Diminazene; Enzyme Activators; Female; Heart; Hypertension, Pregnancy-Induced; Kidney; Male; Myocardial Contraction; Peptide Fragments; Peptidyl-Dipeptidase A; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Ventricular Function, Left | 2019 |